P107 Chromosomal abnormalities in Philadelphia chromosome-negative metaphases appearing during imatinib mesylate therapy in patients with Philadelphia chromosome positive chronic m... by Jootar, S

Get full text

The price of drugs for chronic myeloid leukemia (CML) is a reflection of the unsustainable prices of cancer drugs: from the perspective of a large group of CML experts by Abboud, Camille, Berman, Ellin, Cohen, Adam, Cortes, Jorge, DeAngelo, Daniel, Deininger, Michael, Devine, Steven, Druker, Brian, Fathi, Amir, Jabbour, Elias, Jagasia, Madan, Kantarjian, Hagop, Khoury, Jean, Laneuville, Pierre, Larson, Richard, Lipton, Jeffrey, Moore, Joseph O., Mughal, Tariq, O’Brien, Susan, Pinilla-Ibarz, Javier, Quintas-Cardama, Alfonso, Radich, Jerald, Reddy, Vishnu, Schiffer, Charles, Shah, Neil, Shami, Paul, Silver, Richard T., Snyder, David, Stone, Richard, Talpaz, Moshe, Tefferi, Ayalew, Van Etten, Richard A., Wetzler, Meir, Abruzzese, Elisabetta, Apperley, Jane, Breccia, Massimo, Byrne, Jenny, Cervantes, Francisco, Chelysheva, Ekaterina, Clark, R. E., de Lavallade, Hugues, Dyagil, Iryna, Gambacorti-Passerini, Carlo, Goldman, John, Haznedaroglu, Ibrahim, Hjorth-Hansen, Henrik, Holyoake, Tessa, Huntly, Brian, le Coutre, Philipp, Lomaia, Elza, Mahon, Francois-Xavier, Marin-Costa, David, Martinelli, Giovanni, Mayer, Jiri, Milojkovic, Dragana, Olavarria, Eduardo, Porkka, Kimmo, Richter, Johan, Rousselot, Philippe, Saglio, Giuseppe, Saydam, Guray, Stentoft, Jesper, Turkina, Anna, Vigneri, Paolo, Zaritskey, Andrey, Aguayo, Alvaro, Ayala, Manuel, Bendit, Israel, Maria Bengio, Raquel, Best, Carlos, Bullorsky, Eduardo, Cervera, Eduardo, DeSouza, Carmino, Fanilla, Ernesto, Gomez-Almaguer, David, Hamerschlak, Nelson, Lopez, Jose, Magarinos, Alicia, Meillon, Luis, Milone, Jorge, Moiraghi, Beatriz, Pasquini, Ricardo, Pavlovsky, Carolina, Ruiz-Arguelles, Guillermo J., Spector, Nelson, Arthur, Christopher, Browett, Peter, Grigg, Andrew, Hu, Jianda, Huang, Xiao-jun, Hughes, Tim, Jiang, Qian, Jootar, Saengsuree, Kim, Dong-Wook, Malhotra, Hemant, Malhotra, Pankaj, Matsumura, Itaru, Melo, Junia, Ohnishi, Kazunori

Get full text

Efficacy and safety of radotinib in chronic phase chronic myeloid leukemia patients with resistance or intolerance to BCR-ABL1 tyrosine kinase inhibitors by Kim, Sung-Hyun, Menon, Hari, Jootar, Saengsuree, Saikia, Tapan, Kwak, Jae-Yong, Sohn, Sang-Kyun, Park, Joon Seong, Jeong, Seong Hyun, Kim, Hyeoung Joon, Kim, Yeo-Kyeoung, Oh, Suk Joong, Kim, Hawk, Zang, Dae Young, Chung, Joo Seop, Shin, Ho Jin, Do, Young Rok, Kim, Jeong-A, Kim, Dae-Young, Choi, Chul Won, Park, Sahee, Park, Hye Lin, Lee, Gong Yeal, Cho, Dae Jin, Shin, Jae Soo, Kim, Dong-Wook

Get full text

Bortezomib plus rituximab versus rituximab alone in patients with relapsed, rituximab-naive or rituximab-sensitive, follicular lymphoma: a randomised phase 3 trial by Coiffier, Bertrand, Prof, Osmanov, Evgenii A, Prof, Hong, Xiaonan, Prof, Scheliga, Adriana, MD, Mayer, Jiri, Prof, Offner, Fritz, Prof, Rule, Simon, MD, Teixeira, Adriana, MD, Walewski, Jan, Prof, de Vos, Sven, MD, Crump, Michael, Prof, Shpilberg, Ofer, Prof, Esseltine, Dixie-Lee, MD, Zhu, Eugene, PhD, Enny, Christopher, BS, Theocharous, Panteli, PhD, van de Velde, Helgi, MD, Elsayed, Yusri A, MD, Zinzani, Pier Luigi, Prof

Get full text

DNA detection of chronic myelogenous leukemia by magnetic nanoparticles by JANGPATARAPONGSA, Kulachart, POLPANICH, Duangporn, YAMKAMON, Vichanan, DITTHAROT, Yuranun, PENG-ON, Jutharat, THIRAMANAS, Raweewan, HONGENG, Suradej, JOOTAR, Saengsuree, CHAROENMAK, Lalida, TANGBORIBOONRAT, Pramuan

Get full text

The association of anti-r-HuEpo-associated pure red cell aplasia with HLA-DRB109-DQB10309 by Praditpornsilpa, Kearkiat, Kupatawintu, Pawinee, Mongkonsritagoon, Wichean, Supasyndh, Ouppatham, Jootar, Saengsuree, Intarakumthornchai, Tanin, Pongskul, Cholatip, Prasithsirikul, Wisit, Achavanuntakul, Bunlersak, Ruangkarnchanasetr, Prajej, Laohavinij, Sudsawat, Eiam-Ong, Somchai

Get full text

A Prospective Randomized Study of Chop Versus Chop Plus Alpha-2B Interferon in Patients with Intermediate and High Grade Non-Hodgkin's Lymphoma: The International Oncology Study Gr... by Giles, Francis J., Shan, Jianqin, Advani, Suresh H., Akan, Hamdi, Aziz, Zeba, Azim, Hamdy A., Bapsy, P. P., Buyukkececi, Filiz, Chaimongkol, Boonsoom, Cheong, Soon-Keng, Hamza, Reda, Khalid, Hussein M., Intragumtornchai, Tanin, Kim, Sang W., Kim, Sam Y., Koc, Haluk, Kumar, Lalit, Kumar, Ravi, Lei, Kenny I., Lekhakula, Arnuparp, Muthalib, Abdul, Patel, Moosa, Poovalingam, Viz P., Prayoonwiwat, Wichai, Rana, Fauzia, Reksodiputro, Arryanto H., Ruff, Paul, Sagar, T. G., Schwarera, Andrew P., Suharti, Catherine, Supindiman, Iman, Tee, Goh Y., Thamprasit, Taratorn, Villalon, Antonio H., Wickham, Nicholas R., Wong, John E., Yalcin, Attila

Get full text

Dasatinib (SPRYCEL®) vs Escalated Dose of Imatinib (im) in Patients (pts) with Chronic Phase Chronic Myeloid Leukemia (CP-CML) Resistant to Imatinib: Results of the CA180-017 START... by Shah, Neil, Pasquini, R., Rousselot, P., Jootar, S., Holowiecki, J., Countouriotis, A., Dejardin, D., Hughes, T., Druker, Brian J.

Get full text

Myelodysplastic syndromes in Thailand: a retrospective pathologic and clinical analysis of 117 cases by Intragumtornchai, Tanin, Prayoonwiwat, Wichai, Swasdikul, Daratana, Suwanwela, Nipha, Chaimongkol, Boonsom, Jootar, Saengsuree, Chansung, Kanchana, Chancharunee, Suporn, Leelasiri, Apichai, Yoshida, Yataro

Get full text

Clinical guidelines for the management of cancer patients with neutropenia and unexplained fever by Jun, Huang Xiao, Zhixiang, Shen, Chun, Wang, Reksodiputro, A. Harryanto, Ranuhardy, Dody, Tamura, Kazuo, Matsumoto, Tetsuro, Lee, Dong-Gun, Purushotaman, S. Visalachy, Lim, Victor, Ahmed, Altaf, Hussain, Yasser, Chua, Manolito, Ong, Adrian, Liu, Cheng-Yi, Hsueh, Po-Ren, Lin, Shaeng-Fung, Liu, Yung-Ching, Suwangool, Panpit, Jootar, Saengsuree, Picazo, Juan J.

Get full text

Outcome of transplantation with unrelated donor bone marrow in children with severe thalassemia by Pakakasama, S., Hongeng, S., Chaisiripoomkere, W., Chuansumrit, A., Ungkanont, A., Jootar, S.

Get full text

206HLA-identical allogenicc peripheral blood stem cell transplantation in homozygous β thalassemia and severe β thalassemia/hemoglobin E disease patients by Pakakasama, S., Hongeng, S., Chaisiripoomkere, W., Chuansumrit, A., Sirachainan, N., Jootar, S.

Get full text

Phase III Clinical Trial (RERISE study) Results of Efficacy and Safety of Radotinib Compared with Imatinib in Newly Diagnosed Chronic Phase Chronic Myeloid Leukemia by Kwak, Jae-Yong, Kim, Sung-Hyun, Oh, Suk Joong, Zang, Dae Young, Kim, Hawk, Kim, Jeong-A, Do, Young Rok, Kim, Hyeoung Joon, Park, Joon Seong, Choi, Chul Won, Lee, Won Sik, Mun, Yeung-Chul, Kong, Jee Hyun, Chung, Joo Seop, Shin, Ho-Jin, Kim, Dae-Young, Park, Jinny, Jung, Chul Won, Bunworasate, Udomsak, Comia, Narcisa Sonia, Jootar, Saengsuree, Reksodiputro, Arry Harryanto, Caguioa, Priscilla B, Lee, Sung-Eun, Kim, Dong-Wook

Get full text

Dasatinib or high-dose imatinib for chronic-phase chronic myeloid leukemia after failure of first-line imatinib: a randomized phase 2 trial by Kantarjian, Hagop, Pasquini, Ricardo, Hamerschlak, Nelson, Rousselot, Philippe, Holowiecki, Jerzy, Jootar, Saengsuree, Robak, Tadeusz, Khoroshko, Nina, Masszi, Tamas, Skotnicki, Aleksander, Hellmann, Andrzej, Zaritsky, Andrey, Golenkov, Anatoly, Radich, Jerald, Hughes, Timothy, Countouriotis, Athena, Shah, Neil

Get full text

Dasatinib or High-Dose Imatinib for Chronic-Phase Chronic Myeloid Leukemia Resistant to Imatinib at a Dose of 400 to 600 Milligrams Daily: Two-Year Follow-Up of a Randomized Phase... by KANTARJIAN, Hagop, PASQUINI, Ricardo, SHAH, Neil P, LEVY, Vincent, JOOTAR, Saengsuree, HOLOWIECKI, Jerzy, HAMERSCHLAK, Nelson, HUGHES, Timothy, BLEICKARDT, Eric, DEJARDIN, David, CORTES, Jorge

Get full text

Chronic myeloid leukemia in Asia by Au, Wing Y., Caguioa, Priscilla B., Chuah, Charles, Hsu, Szu Chun, Jootar, Saengsuree, Kim, Dong-Wook, Kweon, Il-Young, O’Neil, William M., Saikia, Tapan K., Wang, Jianxiang

Get full text

Cost-Utility Analysis of Dasatinib and Nilotinib in Patients With Chronic Myeloid Leukemia Refractory to First-Line Treatment With Imatinib in Thailand by Kulpeng, Wantanee, MSc, Sompitak, Sumalai, BSc, Jootar, Saengsuree, MD, Chansung, Kanchana, MD, Teerawattananon, Yot, MD, PhD

Get full text

Practical Laboratory Tools for Monitoring of BCR-ABL1 Transcripts and Tyrosine Kinase (TK) Domain Mutations in Chronic Myeloid Leukemia Patients Undergoing TK Inhibitor Therapy: A... by Limsuwanachot, Nittaya, Kongruang, Adcharee, Rerkamnuaychoke, Budsaba, Singdong, Roongrudee, Niparuck, Pimjai, Jootar, Saengsuree, Siriboonpiputtana, Teerapong

Get full text

Long‐term data from a phase 3 study of radotinib versus imatinib in patients with newly diagnosed, chronic myeloid leukaemia in the chronic phase (RERISE) by Do, Young Rok, Kwak, Jae‐Yong, Kim, Jeong A., Kim, Hyeoung Joon, Chung, Joo Seop, Shin, Ho‐Jin, Kim, Sung‐Hyun, Bunworasate, Udomsak, Choi, Chul Won, Zang, Dae Young, Oh, Suk Joong, Jootar, Saengsuree, Reksodiputro, Ary Harryanto, Lee, Won Sik, Mun, Yeung‐Chul, Kong, Jee Hyun, Caguioa, Priscilla B., Kim, Hawk, Park, Jinny, Kim, Dong‐Wook

Get full text

Impact of Early Switching to Nilotinib As Second Line TKI in Patients with Chronic Myeloid Leukemia Who Were Intolerant to, Suboptimal to and Failed Imatinib: The Thai Multi-Center... by Viboonjuntra, Pongtep, Lekhakula, Arnuparp, Chansung, Kanchana, Sirijerachai, Chittima, Niparuck, Pimjai, Pauvilai, Teeraya, Numbenjapon, Tontanai, Bunworasate, Udomsak, Nawarawong, Weerasak, Tantiworawit, Adisak, Suwanban, Tawatchai, Jootar, Saengsuree

Get full text